DrugPipeline.net has announced the addition of “US Market Report for Spinal Machined Bone Allograft 2017 - MedCore” research report to their website DrugPipeline.net
Bangalore, Karnataka -- (SBWIRE) -- 03/10/2017 -- General Report Contents
- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
- Market Drivers & Limiters for each chapter segment
- Competitive Analysis for each chapter segment
- Section on recent mergers & acquisitions
The 2016 spinal machined bone allograft market comprises anterior, posterior, transforminal and cervical interbody fusions. Anterior lumbar interbody fusion represented the largest segment. Closely following was CIF, PLIF and TLIF. The proportion of the machined bone allograft market by treatment will remain similar over the forecast period; the greatest change will be for the CIF segment, which will become the largest in the market by 2023.
All segments of this market will decline, experiencing both dropping unit sales and average selling prices. The PLIF and ALIF segments will be hit the hardest. Even though the number of spinal fusions performed in the United States is growing, this growth is associated with increased PEEK usage rather than machined bone allograft.
Spinal fusion is a surgical procedure designed to combine two or more vertebrae together, eventually forming a fused bone. It is primarily used for eliminating or significantly reducing the pain caused by abnormal movement of the vertebrae by immobilizing them. Supplemental bone tissue, either autograft or allograft, is used for promoting bone growth. A union of two vertebral bodies is referred to as a single-level fusion. Fusion is accomplished by using either an instrumented or non-instrumented surgical approach. Instrumented fusions incorporate fixation devices to secure and stabilize the fusion site, and interbody devices are used for filling the intervertebral disc space to enhance and promote fusion. Non-instrumented fusions utilize bone tissue to promote growth, but do not incorporate any implant devices into the procedures.
Spanning over 467 pages "US Market Report for Spinal Machined Bone Allograft 2017 - MedCore" report covers Executive Summary, U.S. Orthopedic Biomaterials Market Overview, Competitive Analysis, Market Trends, Research Methodology, Disease Overview, Product Assessment, Spinal Machined Bone Allograft Market, Appendix. The Report covered companies are - Medtronic, Genzyme, DePuy Synthes, Anika Therapeutics, Ferring Pharmaceuticals, Stryker, NuVasive, Bioventus, Zimmer Biomet, Integra LifeSciences, RTI Surgical, Fidia Pharmaceuticals, MTF, Orthofix, Arthrex, AlloSource, Aastrom, Baxter, Harvest Technologies, Wright Medical, Bacterin International, Arteriocyte, Exactech, LifeNet Health, Biocomposites, Alphatec Spine, Celling Biosciences, Globus Medical, Nuo Therapeutics, K2M,
For more information Visit at: http://www.drugpipeline.net/idata-research/us-market-report-spinal-machined-bone-allograft-2017-medcore
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.